Shares of Silk Road Medical are down 19% or $6.16 at $26.49 as The Centers for Medicare & Medicaid Services has entered a guideline on coverage for Percutaneous Transluminal Angioplasty of the Carotid Artery Concurrent with Stenting.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SILK: